ATI Physical Therapy Inc is a medical care facilities business based in the US. ATI Physical Therapy shares (ATIP) are listed on the NYSE and all prices are listed in US Dollars. ATI Physical Therapy employs 2,412 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $3.20 |
|---|---|
| 52-week range | $2.66 - $13.05 |
| 50-day moving average | $3.39 |
| 200-day moving average | $5.94 |
| Wall St. target price | $4.83 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-3.98 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.2 from 2022-01-24
| 1 week (2022-01-18) | -13.98% |
|---|---|
| 1 month (2021-12-23) | -3.03% |
| 3 months (2021-10-25) | 14.29% |
| 6 months (2021-07-23) | -61.63% |
| 1 year (2021-01-25) | -73.49% |
|---|---|
| 2 years (2020-01-21) | N/A |
| 3 years (2019-01-21) | N/A |
| 5 years (2017-01-21) | N/A |
Valuing ATI Physical Therapy stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ATI Physical Therapy's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ATI Physical Therapy's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15.1 million.
The EBITDA is a measure of a ATI Physical Therapy's overall financial performance and is widely used to measure a its profitability.
To put ATI Physical Therapy's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $607.6 million |
|---|---|
| Gross profit TTM | $269.6 million |
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | -129.19% |
| Book value | $2.51 |
| Market capitalisation | $733.8 million |
TTM: trailing 12 months
We're not expecting ATI Physical Therapy to pay a dividend over the next 12 months.
You may also wish to consider:
ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy, work conditioning, hand therapy, aquatic therapy, functional capacity assessment, sports medicine, wellness programs, and home health. The company provides outpatient physical therapy services under the ATI Physical Therapy name. As of March 31, 2021, it had 882 owned and 22 managed clinics. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.